Am I a Candidate for HIFU Treatment? How Doctors Decide
“Am I a candidate for HIFU treatment?” is one of the most important questions to answer before considering a non-surgical treatment for uterine fibroids or adenomyosis. The short answer is that candidacy is not determined by one factor—such as fibroid size, age, or a desire to avoid surgery. A specialist must connect your symptoms, diagnosis, imaging findings, medical history, and reproductive goals to a treatment plan that can be performed safely.
At Barungil OB/GYN Clinic in Seoul, HIFU is recommended only when a physician-led assessment indicates that it is an appropriate option. This article explains how doctors evaluate HIFU candidacy, why MRI and ultrasound matter, and when another treatment may be a better choice.
What Does HIFU Treat?
High-intensity focused ultrasound (HIFU) is a non-invasive thermal ablation technique. Multiple ultrasound beams are focused on a selected target within the uterus, producing controlled heat at the focal point. The aim is to ablate targeted tissue without a surgical incision. In gynecology, HIFU may be considered for selected patients with symptomatic uterine fibroids or adenomyosis. [1] [2]
However, a diagnosis alone does not establish candidacy. Some people have fibroids or adenomyosis that do not explain their symptoms; others have lesion characteristics or an ultrasound pathway that makes HIFU less suitable. The best treatment is the one that matches the patient—not simply the newest technology.
The Four Questions That Shape HIFU Candidacy
A thoughtful consultation begins with four clinical questions. Each question matters because HIFU is a precision treatment: the target must be clinically relevant, visible on imaging, and safely accessible.
| Clinical question | Why it matters |
|---|---|
| Are your symptoms likely caused by a fibroid or adenomyosis? | Bleeding, pain, pressure, urinary frequency, anemia, and fertility concerns can have more than one cause. The target lesion should plausibly explain the problem being treated. |
| Is the diagnosis clear? | Ultrasound, MRI, and gynecologic assessment help distinguish fibroids, adenomyosis, and other pelvic conditions that may require a different pathway. |
| Can HIFU reach the target safely? | The physician assesses the route from the abdominal wall to the target, including bowel, scars, depth, bone, and nearby nerves. |
| Do your goals fit a uterus-preserving approach? | Future pregnancy plans, symptom priorities, tolerance for follow-up, and openness to other treatments all influence the recommendation. |
1. You Have Symptoms That Match the Condition
HIFU is generally considered for people with symptoms that meaningfully affect quality of life. With uterine fibroids, these may include heavy or prolonged menstrual bleeding, pelvic pressure, frequent urination, constipation, pain, or a visibly enlarged abdomen. With adenomyosis, common concerns include severe menstrual pain, heavy bleeding, chronic pelvic pain, and anemia. [2] [3]
The key question is not simply, “Do you have a fibroid?” It is, “Is this fibroid or adenomyosis pattern likely responsible for the symptoms you want to improve?” A small lesion in one location can create significant symptoms, while a larger lesion elsewhere may not. This connection between symptoms and imaging is the foundation of responsible treatment planning.
2. Your Imaging Supports Safe, Targeted Treatment
Imaging is not a formality before HIFU—it is central to the decision. Transvaginal ultrasound can help identify uterine pathology and evaluate its location. MRI may provide additional detail about the lesion’s size, number, tissue characteristics, blood supply, and relationship to the uterine cavity and outer uterine surface. For adenomyosis, MRI can also clarify whether disease is focal or diffuse and help define the relevant treatment target. [1] [3]
For fibroids, imaging characteristics such as location, tissue signal, and perfusion can influence how well a target is expected to respond. For adenomyosis, lesion pattern, vascularity, and position can influence both the technical plan and the expected clinical response. These are not rules that a patient should interpret alone; they are factors a specialist reviews together.
3. There Is a Safe Acoustic Pathway
HIFU energy must travel safely from the skin to the target. Doctors therefore examine the acoustic pathway: the route taken by the ultrasound beam. Bowel loops, abdominal scars, substantial tissue depth, and a target close to bone or nerves can make treatment more complex or may lead the physician to recommend another approach. [1] [4]
Previous abdominal surgery or a cesarean delivery does not automatically rule out HIFU. However, a scar in the planned pathway must be assessed carefully because scar tissue can affect energy transmission and may increase the risk of unwanted heating. Similarly, a posterior target near the sacrum requires careful planning because bone absorbs ultrasound energy differently from soft tissue. The presence of these issues does not always mean “no,” but it does mean that imaging review and safety planning are essential.
4. Your Fibroid or Adenomyosis Pattern Is Treatable
There is no universal size cutoff that applies to every HIFU system, every lesion, or every patient. A treatment plan considers more than size: it also reviews the number of targets, their position, their accessibility, tissue characteristics, and how much clinically relevant tissue can be treated safely in a reasonable session. Published research on focused ultrasound consistently emphasizes that these technical and imaging factors influence treatment feasibility and outcome. [1] [4]
For example, a single, accessible symptomatic fibroid may be easier to plan than several targets scattered throughout the uterus. A fibroid that is close to the endometrium, attached by a narrow stalk, heavily calcified, or hidden behind bowel may need a different strategy. With adenomyosis, focal and diffuse disease can require different discussions. The correct conclusion is not that one pattern is “good” or “bad,” but that each case requires an individualized technical review.
Who May Be a Good Candidate for HIFU?
You may be a candidate for HIFU if you have symptomatic fibroids or adenomyosis, wish to explore a non-surgical and uterus-preserving option, and your imaging shows a target that can be reached safely. People who want to avoid a surgical incision, have concerns about recovery time, or want to discuss fertility preservation often ask about HIFU. The final recommendation still depends on a complete evaluation.
- You have bleeding, pain, pressure, or bulk symptoms linked to a fibroid or adenomyosis lesion.
- Your diagnosis has been evaluated by a gynecologist using appropriate imaging.
- The target is accessible through a safe acoustic pathway.
- Your lesion characteristics support a reasonable treatment plan.
- You understand that HIFU is one option among medication, surgery, and other interventions.
- You are willing to participate in planned follow-up after treatment.
When Might HIFU Not Be the Best Choice?
HIFU is not suitable for every situation. A different pathway may be safer or more effective when the diagnosis is uncertain, a malignancy is suspected, there is an acute pelvic infection, the patient is pregnant, or the target cannot be reached through a safe pathway. Some fibroid and adenomyosis patterns may also be better addressed with medication, hysteroscopic treatment, myomectomy, uterine artery embolization, or hysterectomy, depending on symptoms and goals. [2] [3]
Most importantly, being told that HIFU is not appropriate is not a failure. It is a sign that the treatment recommendation is being made with safety and long-term care in mind.
What About Pregnancy and Fertility?
HIFU preserves the uterus because it does not remove it. Pregnancies have been reported after focused ultrasound treatment, but no procedure can guarantee fertility or a particular pregnancy outcome. Fertility depends on many factors, including age, ovarian reserve, fallopian tubes, sperm factors, the location of fibroids, adenomyosis severity, and prior reproductive history. [2] [3]
If pregnancy is one of your priorities, it should be discussed at the beginning of the consultation—not after a treatment plan is already chosen. A physician can help coordinate the HIFU discussion with fertility evaluation or IVF planning when appropriate.
How Dr. Kil Assesses HIFU Suitability
At Barungil OB/GYN Clinic, Dr. Ki Hyon Kil, M.D., Ph.D., reviews each case individually. Dr. Kil holds a doctorate in Obstetrics and Gynecology from Catholic University and has personally performed more than 2,400 HIFU procedures over the past decade. His assessment focuses on whether the treatment is appropriate for the individual patient—not simply whether HIFU can be offered.
- Review the symptoms and priorities: bleeding, pain, pressure, anemia, fertility plans, and previous treatments.
- Confirm the diagnosis: determine whether the relevant issue is fibroids, adenomyosis, or another condition.
- Review imaging: assess lesion type, location, size, vascularity, and the acoustic pathway.
- Discuss all reasonable options: including HIFU, medication, surgery, and other interventions where relevant.
- Plan follow-up: agree on symptom monitoring and imaging after treatment when HIFU is selected.
Frequently Asked Questions
Am I a candidate for HIFU treatment?
You may be a candidate if you have symptomatic fibroids or adenomyosis and imaging shows that the target can be reached safely. Final suitability depends on your symptoms, diagnosis, lesion characteristics, acoustic pathway, medical history, and reproductive goals.
Can HIFU treat large fibroids?
Some larger fibroids can be treated, but size alone does not determine eligibility. The number of targets, location, blood supply, safe access, and expected treatment time are also important. A specialist must review your imaging before making a recommendation.
Can I have HIFU after a C-section or myomectomy?
Previous surgery does not automatically exclude HIFU. The specialist will review scar position and the planned ultrasound pathway to determine whether treatment can be performed safely.
Do I need an MRI before HIFU?
MRI is often valuable for evaluating lesion pattern, location, size, tissue characteristics, and treatment accessibility. Your doctor will determine which imaging is needed after reviewing your history and ultrasound findings.
Can I get pregnant after HIFU?
HIFU preserves the uterus, and pregnancies have been reported after treatment. However, fertility and pregnancy outcomes are individual, so future pregnancy plans should be discussed with your gynecologist or fertility specialist before choosing treatment.
What happens if I am not a candidate for HIFU?
You can still discuss other evidence-based options. Depending on your condition and goals, these may include medication, a different minimally invasive intervention, myomectomy, or hysterectomy. The right answer is the option that best matches your needs and safety considerations.
Request a Personalized HIFU Consultation
If you have been diagnosed with uterine fibroids or adenomyosis and would like to know whether HIFU may be appropriate, book a consultation with Barungil OB/GYN Clinic. We will review your medical history, symptoms, and imaging to discuss the treatment options that fit your situation.
Medical note: This article is for general education and does not replace individual medical assessment, diagnosis, or treatment advice.
References
- Nguyen Minh Duc, Keserci B. Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids. Diagnostic and Interventional Radiology. 2018.
- Bahutair SN, Alhubaishi LY. High-intensity focused ultrasound in adenomyosis treatment: Insights on safety, efficacy, and reproductive prospects. Women’s Health. 2024.
- Lin CW, et al. Expert Consensus on the Management of Adenomyosis. Gynecology and Minimally Invasive Therapy. 2025.
- Abdullah BJJ, et al. Magnetic resonance-guided focused ultrasound surgery treatment for uterine fibroids. Biomedical Imaging and Intervention Journal. 2010.
